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Physicians enjoy considerable liberty in the creation of entrepreneurial ventures in the new frontiers of 
medicine. Professional societies may opine about a new procedure but professionals may feel free to 
ignore their counsel as well. Two case studies are used to discuss this method of new venture creation; 
the cases are trait selection through pre-implantation genetic diagnosis and female cosmetic genital 
surgery (FCGS), both controversial practices. We discuss the ethics and legitimacy of both and how one 
can use theory to analyze whether or not these are legitimate businesses and how to develop them.
RELEVANT THEORY AND LITERATURE
     Three management and sociological theories are relevant here: industry life cycle model (Hofer, 1975; 
Hill & Jones, 2010), embeddedness theory (Granovetter, 1985; Zelizer, 1978), and institutional 
entrepreneurship theory (Maguire, Hardy, et al., 2004; Greenwood & Suddaby, 2006). The industry life
cycle model depicts the various stages in an industry’s evolution over time, from embryonic, growth,
shaking-out, mature, and eventually to a decline stage. It delineates noteworthy strategic issues in each
stage and helps us explain difficulties encountered in commercializing new services. The embeddedness 
theory emphasizes that economic activities such as commercializing a new technology are embedded 
within relational and cultural contexts. Cultural beliefs tend to enable as well as constrain economic 
actions. It also helps us explain the role of ethics as a social force in legitimating a business. The 
institutional entrepreneurship theory indicates the possibility that actors can take strategic action to 
influence or shape institutional structures or cultural beliefs to create a benign environment for their
business. We also suggest that sensible strategic plans be developed to help legitimate the new businesses 
based on the theory of institutional entrepreneurship.
Legitimacy connotes the kind of social integration that commands public respect as a consequence of 
substantial ethical and legal approval. New technologies should not regard engagement with ethics or the 
law as a contest in which the values of others must yield to business interests but rather new technologies 
should conform to accepted ethical standards and legal requirements. The advantage of oversight for such 
complex technologies as genetically-engineered organisms and nanotechnology has been recognized by
experts, even though the criteria for oversight varies (Kuzma, Najmaie, & Larson, 2009). Although legal 
64 Journal of Applied Business and Economics vol. 12(4) 2011 
  
     
 
  
 
 
 
 
 
 
 
 
     
 
 
 
 
 
 
 
     
 
 
 
   
regulatory oversight can arise from or intensify after a health or safety crisis, oversight ideally arises in a 
pro-active manner, from the holders of the technological prowess: the makers themselves. This was 
demonstrated by the scientific community that conferred years ago at Asilomar in California, resulting in 
scientists pressuring government to intervene with guidelines to govern research on recombinant DNA 
(Kuzma et al., 2009, p. 547). Such a demand for oversight represents more than an effort to provide
safety; it represents a conscientious ethical decision to develop technologies in accord with what is best 
for humanity. 
If new technologies are to be incorporated into society with public approval, it would seem logical that 
both experts within a field (not just a business) as well as governmental agencies should be brought into 
the dialogue of what merits pursuit. For example, Wall and Brown (2010, p. 30e1), criticized the “trend
toward prepackaged surgical procedures” being shaped by commercial interests. 
     Ethical concerns associated with genetically engineered organisms, such as impact on social systems,
rights of consumers to understand the products or services, health and safety, and “opportunities to object 
to the technology on moral grounds” (Kuzma et al., 2009, p. 550) can be extended to other new 
technologies. Trait selection is one such case. 
TRAIT SELECTION CASE
     In February 2009, Dr. Jeff Steinberg announced that his clinic, The Fertility Institutes, based in Los 
Angeles, would use pre-implantation genetic diagnosis (PGD) to help prospective parents select their
babies’ hair and/or eye color. Immediately after the media coverage of the initiative, some doctors 
expressed doubts regarding its technical feasibility, and some religious groups and bioethicists questioned
its ethics. Amidst ethical controversies and technological uncertainty, Steinberg faced challenges to 
legitimate the trait selection business.
Legitimizing Trait Selection as a New Technology 
When a new technology, PGD in this case, lays a foundation to a potential new line of business (e.g., 
the trait selection business), strategic entrepreneurs need to learn how to deal with issues peculiar to the 
embryonic stage of an industry. Furthermore, a technology is not always value neutral, but can involve 
ethical controversies. Entrepreneurs should assess the ethical implications of the technology and 
formulate strategies to shape the institutional environment to their advantage by overcoming the
presenting hurdles.
Hurdles 
     The hurdles Steinberg faced included undeveloped technology, lack of customer demand, the threat of 
regulation, and ethical dilemmas. According to the industry life cycle model, technology in an embryonic 
stage, the earliest stage of the life cycle of an industry, is usually immature. Entrepreneurs need to focus 
on improving and eventually perfecting the technology to provide quality products or services. In the case 
of trait selection, regardless of ethical controversies, the technology that Steinberg plans to use to deliver
his announced service is far from mature. Sean Tipton of the American Society for Reproductive 
Technology commented, “Nobody can do this right now” (Salamone, Dillon & Pesce, 2009). Even
Steinberg himself acknowledged that “it’s not perfect science because eye and hair colors are not perfect 
genetics” (Salamone, et al., 2009). It seemed that he had not been able to use PGD to identify accurately 
and consistently genetic materials that determine a baby’s hair and eye pigmentation. Failure to deliver
what he promised would definitely compromise the viability of his proposed business.
The PGD procedure needs to extract one or two cells from a three-day-old embryo for genetic 
diagnosis. The loss of the cells may damage the embryo and lead to irreversible side effects on it and,
eventually, the person developing from it. Since few babies resulting from the PGD procedure have 
reached adulthood yet, more time is needed to evaluate accurately the implications of the PGD procedure 
for their health. Therefore, some medical practitioners believe that the PGD technology is still in an
experimental stage (Kalfoglou, 2005).
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The PGD procedure is subject to misdiagnosis. For example, cells extracted from an embryo may have 
different genetic compositions from cells left intact in the embryo. Thus, results from the diagnosis may
not be generalized to other cells. For example, genes related to blue eyes may be found in an extracted 
and diagnosed cell, but may be missing from intact cells in an embryo.
     No representative sample about misdiagnosis is available. But according to research based on
convenience samples, the misdiagnosis rate is rather high; one study reported that three of seven pregnant 
PGD patients were misdiagnosed (Kalfoglou, 2005).
Until Steinberg and his colleagues can improve their PGD technology to increase diagnostic accuracy, 
the trait selection business may not be able to take off.
     In the embryonic stage of an industry, there is usually a low demand for a new product or service. 
Potential customers tend to be unaware of or unfamiliar with the product or service. Entrepreneurs need to 
invest heavily in marketing. In addition, lacking the economies of scale, the price of the product or service 
tends to be high, which suppresses demand. 
     Furthermore, as mentioned earlier, the immature technology in trait selection may not serve a 
customer’s needs well. Since results are not necessarily guaranteed, prospective parents would face an 
ethical or emotional dilemma if a conceived baby turns out to be different from what they ordered. 
To use PGD to select traits, prospective parents need to go through the In Vitro Fertilization
procedure, which may cause physical and psychological discomfort. Moreover, the healthy embryos will
be discarded simply due to the lack of potential for specific hair or eye color, which could cause moral 
qualms among some prospective parents who believe that an embryo deserves to grow to fruition. Healthy 
embryos are routinely discarded by fertility clinics because usually only one or two are expected to grow
into children in the implantation phase. Physical and psychological inconvenience and moral ambiguities
tend to suppress demand from potential customers though there are many willing customers for PGD 
should the parents be fearful of a genetic disease or have a specific gender preference, a big part of
Steinberg’s business. 
     It is likely that prospective parents’ preference for a certain hair or eye color is influenced by public
opinion as conveyed through the media. The aesthetic taste of the public may be fickle. A fashionable eye 
color may cease its popularity after a short while. The fluidity of taste poses a risk to the prospective 
parents that traits selected for their children might be out of fashion at some point.
The genetic pool of parents defines the range of the possible physiological features that can be found
in their descendants. Some Caucasians (e.g., Scandinavians) can more readily have blue eyes and blond 
hair, for example. If there is no genetic disposition for some trait in prospective parents of other
ethnicities, the PGD procedure won’t be able to help them to bear a child with that trait unless they use 
sperm or eggs from donors.
     To leap over the customer demand hurdle, entrepreneurs need to help customers to overcome the fear
of physical and psychological uneasiness related to the IVF procedure and to ease the moral qualms about 
the disintegration of screened-out embryos. They could also attempt to expand the portfolio of traits 
available for selection, thereby increasing the size of potential customers who may insist on using their
own sperm and/or eggs. Perhaps athletic parents would choose to order extremely tall boys, technology 
permitting. 
There is no federal or state legislation that prohibits or limits non-medical trait selection practices in
the United States, although gender selection for non-medical purposes is illegal in Canada and the UK 
(see http://www.fertilityfactor.com/infertility_sex_selection.html). However, there is no assurance
that federal or state legislatures won’t regulate or even ban them in the future. Since these practices are 
ethically controversial, representatives from various religious groups voiced their objection. For example, 
Rabbi Mark Popovsky (2007) argued that gender selection and other trait selections are unethical 
according to Judaism. Viewing children as gifts from God, the Vatican denied that prospective parents
have a right to select a child’s traits through medically assisted procreation (Trujillo, 2010, p. 6). Out of 
the consideration of social justice, some jurisprudents and ethicists reason that trait selections may give
children conceived with the PGD method unfair advantages over those conceived through sexual
intercourse. Ethical controversies cast doubts on the legitimacy of the trait selection business. Religious 
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groups and social activists in favor of regulation or a ban on it may mobilize in state or federal 
legislatures to pass restrictive statutes. 
Ethics 
     PGD trait selection has emerged from advances in biotechnology, where the inter-disciplinary aspects 
pose new dilemmas (Poitras & Meredith, 2008, p. 314). Ethical and legal opinions about the practice of 
trait selection tend to vary according to people’s religious backgrounds and theological and philosophical
understandings about life.
First, there is no consensus about when a life is considered to begin. If implanted in a womb, an 
embryo cultured in vitro will potentially develop into a child. When an otherwise healthy embryo is 
disintegrated or destroyed due to the lack of characteristics desired by prospective parents, the child that
would have developed out of it is not given a chance to survive. People who believe that an embryo is the
beginning of a life would consider such destruction equivalent to an abortion.
Second, it is reasonable to assume that prospective parents tend to favor some traits over others. For 
example, blue eyes might be preferred over brown eyes. Groups of people with screened-out traits might 
feel discriminated against and victimized. The trait selection business might suggest the existence of a 
bias against people with certain physical characteristics and, even worse, help to reinforce it. 
     Third, research (Langlois, Kalakanis, Rubenstein, Larson, Hallam, & Smoot, 2000) shows that 
children and adults who are attractive receive more favorable judgment and treatment at the hands of 
others than unattractive children and adults, even when the individuals being so judged or treated are 
known. The same research suggests that attractive individuals tend to display more appealing behaviors
and traits than less attractive individuals. If trait selection is available, selection of appealing traits and 
features by prospective parents is likely to give their children unfair advantages over children who were 
conceived through sexual intercourse. 
     Fourth, some religious traditions consider children as gifts from God. Parental love should not be 
conditioned on what traits children have. Trait selection is likely to set a precondition for parenthood. If 
willingness to parent a child is based on his/her characteristics, it violates humanity; the very existence of 
some children without the desired traits would be cast into doubt. The children might not like their blonde
hair or blue eyes that were specifically selected by their parents, but they are grounded in these trivial 
physical characteristics. This disrespects human dignity.
An ethical view in favor of trait selection reasons that it is a procreation liberty as implied in a 
constitutional right to privacy. A person has a right to avoid reproduction (e.g., abortion) as well as a right 
to procreate. If it is legal to abort a fetus, there is no legal ground to prohibit destroying embryos not 
chosen for implantation. However, some theorists contend that though it is constitutional to have a baby, 
to customize it may go beyond the constitutional protection (Wolfe, 2008). Eventually, the legality of trait 
selection will depend on how a supreme court interprets the constitution of a given jurisdiction, be it a 
state or country. Of course, a government might preemptively passes legislation stipulating that such 
practices are illegal. 
     It may be plausible that public opinion disapproves of the trait selection business. However, it is not
clear whether the opinion can translate into the regulations that ban the practice. Political entrepreneurs 
who intend to solicit support from religious groups or conservative constituents may raise an issue on the 
trait selection business to gain political capital. However, even if there were federal or state regulations
that proscribe the trait selection business, Steinberg, his colleagues, and some patient advocacy groups 
could challenge the legitimacy of the ban in courts.
 The embeddedness theory highlights the difficulty of a business in being accepted as legitimate when it
contradicts ethical beliefs held by part of the society. As federal or state legislatures may regulate or ban
the business, entrepreneurs need to pay institutional costs, lobbying for changes in legislation in their 
favor or challenging a ban in court by resorting to rights protected by the constitution. Furthermore, the 
entrepreneurs need to frame or reframe their business in favorable ethical, philosophical, or even religious
principles or terms, seemingly difficult in the case of trait selection. 
Journal of Applied Business and Economics vol. 12(4) 2011 67 
  
 
 
 
 
  
 
 
 
 
 
 
 
      
 
 
 
 
 
 
   
SWOT analysis
 Using SWOT analysis to legitimate their business, Steinberg needs to analyze opportunities and threats 
in the external environment and identity strengths and weaknesses. He needs to identify major
stakeholders who are important to legitimate the trait selection business. His in vitro fertilization and 
PGD expertise are strengths. He may apply some of this expertise to the proposed non-medical trait 
selection service. Other strengths are his current customer base and former patients that may refer 
potential clients. One of the weaknesses is reliability of the trait selection technology. Another is that he
may not have time or resources to forge coalitions with the interest groups that may be important in 
defending his course if opposing parties mobilize to ban the proposed trait selection business. One 
opportunity in the external environment is a potential new market. If Steinberg could improve the 
technology to increase its accuracy and reliability, he might become a first mover in the new market
segment. He might build up customer loyalty and enjoy price premiums. As mentioned above, major 
threats include technological uncertainty, lack of customer demand, threat of regulations, and ethical 
controversies. 
Unresolved Business Issues
     Technology improvement, marketing, and the regulatory threat are concerns. Legitimization of the trait 
selection business is depicted below (see Figure 1):
Step 1: Perfect genetic technology
Step 2.1 
Identify and 
promote 
customer needs 
Step 2.2 
Identify and 
promote ethical 
arguments that 
legitimate the 
business 
Step 2.3 
Ally with other 
interest groups 
to lobby elected 
officials and 
legislature. 
Step 3: a legitimate business
FIGURE 1 
STRATEGY TO LEGITIMATE THE BUSINESS
Epilogue
For now, Steinberg has postponed the new business initiative (Daily Record, 29 July 2010). It is not
clear if or when he will provide the trait selection business but the controversies will likely continue if he 
goes ahead with the trait selection business. In contrast, Female Cosmetic Genital Surgery (FCGS) is 
ongoing.
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FCGS CASE
Few object to cosmetic procedures to enhance appearance to compensate for apparent shortcomings or
reconstructive surgery to remedy serious problems, including those involving female genitalia. However, 
through photos and films, porn stars may well contribute to the establishment of a standard look for
female genitalia and the worry women may feel about superfluous, cosmetic and heretofore private 
issues; they undergo risky procedures of dubious benefit. Women get photos of female genitalia for 
comparison from pornography and now also from plastic surgeons’ websites. Is FCGS a legitimate 
business? Will sheer numbers in the marketplace determine a standard look for genitalia? What role do 
the professional societies play in determining what’s acceptable? What will the courts decide once claims 
for malpractice and damages become common? Will advocacy groups play a role? Later we will discuss 
the options activists might have.
Legitimizing FCGS as a New Technology 
     The following is a brief situational overview: 
1. The Second Global Symposium on Cosmetic Vaginal Surgery was held on September 23-25, 
2010 in Las Vegas. The International Society of Cosmetogynecology is the professional society 
(www.iscgyn.com). 
2. The numbers of surgeries performed are hard to determine because as of late 2010 the American 
Society of Plastic Surgeons had not as yet published specific statistics on FCGS.
3. Malpractice suits will no doubt occur, typical of medicine in general and perhaps especially in the 
case of a seemingly risky set of procedures performed for what some doctors would call frivolous
ends. 
4. Advocacy groups, including the New View Campaign (www.fsd-alert.org), have begun to make 
their voices heard. 
5. The Royal Australian and New Zealand College of Obstetricians (RANZCOG) has publicly
opposed FCGS (Braun, 2010, p. 1393).
6. At least one professional society in the US has expressed its opposition; the American College of 
Obstetricians and Gynecologists (ACOG) (February 2007) cautioned against "vaginal rejuvenation,"
"designer vaginoplasty," "revirgination," and "G-spot amplification" procedures.
ACOG stated that they are “are not medically indicated, nor is there documentation of their safety and 
effectiveness” and that “it is deceptive to give the impression that any of these procedures are accepted 
and routine surgical practices.” It warned of “potential complications, including infection, altered 
sensation, dyspareunia (pain), adhesions, and scarring.” The report indicated that there was wide variation 
in the external appearance of female genitalia. ACOG (September 1, 2007) was “concerned with the
ethical issues associated with the marketing and national franchising of cosmetic vaginal procedures. A 
business model that controls the dissemination of scientific knowledge is troubling,” We believe this is in 
reference to the practice of training other surgeons for a fee but not publishing the results or practices in 
the medical press.” 
     Liao and Creighton (2007, p. 1091) discussed women’s requests for FCGS: "... our patients sometimes 
cited restrictions on lifestyle for their decision. These restrictions included inability to wear tight clothing, 
go to the beach, take communal showers, or ride a bicycle comfortably, or avoidance of some sexual
practices. Men, however, do not usually want the size of their genitals reduced for such reasons." The 
authors, with a clear bias against FCGS, referred to the current market orientation as a demand for 
“designer vaginas” (p. 1090). They pointed out that in their study of 50 premenopausal women there were 
significant variations in the size, shape, length, color, folds or wrinkles, and symmetry of the various parts 
of female genitalia. Yet women approached the physician with a standard view as though they were going 
to have their hair freshly styled; they brought along desirable images (“usually from advertising or
pornography”, p. 1091).
One letter following the Liao and Creighton article in BMJ, from the editor of Reproductive Health 
Matters, stated: “If a woman (probably African) asks for her own or her daughter’s genitals to be excised 
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for traditional reasons, it is refused as a criminal offense. Yet if a woman thinks her own genitals are an 
abnormal shape or size, the surgery is provided” (Berer, 30 June 2007, p. 1335). A significant difference 
between the two practices is that FCGS is voluntary whereas traditional female genital cutting is often 
imposed on young African girls. 
Hurdles 
     Plastic surgeons as strategic entrepreneurs offering a new technology, such as FCGS in this case, need 
to learn how to deal with issues peculiar to the embryonic stage of an industry. Furthermore, FCGS 
presents ethical controversies, and entrepreneurs should formulate strategies to shape the institutional
environment to their advantage.
In the case of FCGS, regardless of ethical controversies, the technology is far from mature. Peer 
reviewed published studies have not been done. Failure to deliver what plastic surgeons promise would 
compromise the viability of FCGS. Furthermore, if women are harmed, lawsuits could result as well as 
regulatory action.
Potential customers tend to be unaware of or unfamiliar with a new product or service such as FCGS. 
Entrepreneurs need to invest heavily in marketing, which has clearly begun, as a cursory Google search 
(February 7, 2011) for “female cosmetic genital surgery” resulted in “about 375,000 results.” In addition,
lacking the economies of scale, the price of a new product or service tends to be high, which usually 
suppresses demand. Women may be aware of this new service yet remain unconvinced of its importance; 
perhaps they don’t watch enough pornography to have adopted a standardized view of genitalia or they
simply accept individual differences in this private matter. The rate of market growth is unclear, but 
surgeons are promoting FCGS. 
As an immature technology, FCGS may not serve a customer’s needs well. Since results are not 
necessarily guaranteed, prospective patients could face practical or emotional dilemmas; if the procedure
doesn’t work, they may experience constant or intermittent pain and discomfort in sexual relations,
perhaps requiring additional surgeries and procedures, at personal expense.
Physical and psychological inconvenience and moral ambiguities tend to suppress demand from 
potential customers. Some women clearly want “designer vaginas” but other women don’t share a 
uniform view as represented by the exposed porn star, stripper or images on surgeons’ websites. The 
aesthetic taste of the public may be fickle; a fashionable view of genitalia may cease its popularity and the 
fluidity of taste poses a risk to women that select permanent cosmetic changes. 
     Caucasian women comprise approximately 75% of women receiving plastic surgery in the US in 2009 
(American Society of Plastic Surgery, 2010). Appealing to non-white women could broaden the appeal of
FCGS. 
     To leap over the customer demand hurdle, entrepreneurs need to help customers to overcome the fear 
of physical and psychological uneasiness related to FCGS. Some potential customers with genitalia that 
interfere with tightly fitting garments (e.g., bikinis, yoga shorts, & tight shorts) may not accept the porn
standard but still prefer smaller genitalia. Before and after images are provided by plastic surgeons on the 
Internet. 
A business wants to hire the best practitioners, but will the best and brightest plastic surgery residents 
seek out FCGS? It’s too soon to know as FCGS is an immature technology.
Gloria Bachmann expresses her concern as a physician that patients might think an abnormality is 
being addressed and they need to be informed they are receiving cosmetic surgery not reconstruction for 
abnormal function (Goodman, Bachmann, Johnson, Fourcroy, Goldstein, A., Goldstein, G. & Sklar, 2007, 
p. 271). Yet if patients anticipate greater sexual gratification, functionality becomes a motivation. How 
much gratification is realistic might be obscured by the very terminology:
FCGS…includes labia minora reductions, vaginal tightening (“rejuvenation”), labia majora 
“augmentations”, pubic liposuction (mons pubix, labia majora), clitoral hood reductions, hymen 
“reconstruction”, perineum “rejuvenation,” and “G-spot amplification.” A confusing array of
terms associated with even the same procedure has led to calls for standardized nomenclature in 
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this area, which eschews terms that are proprietary and strongly linked to commercialized
medicine, such as laser vaginal rejuvenation (Braun, 2010, p. 1393). 
     A special source of revenue for this type of business could rest in the intellectual property 
opportunities. Some enterprises are already establishing their niche and are ready to license training to
other practitioners. The business would have to consider the possible need to license trademarks. Braun
(2010) provides an interesting illustration: “One of the surgeons most publicizing of FGCS, Dr. Matlock,
appears not to have published anything about his trademarked techniques. However, they are highly 
marketed using (ostensibly) evidence-based claims about outcomes, and Matlock offers training (for a
fee); trained surgeons can then advertise—and use—his techniques” (p. 1401).
     Informed consent in medical procedures demands communication of health risks and what can and
cannot be achieved. In 2007, six physicians with experience in “vulvar health” submitted opinions about 
how physicians should be guided in dealing with patients in the Journal of Sex Health. Michael P.
Goodman stressed the importance of respecting the patient’s wishes, so long as the patient’s desire is not 
superficial (losing a “boyfriend”), but also admits, “Because the purpose frequently is ‘to be tight and
bleed,’ an effective procedure is often the opposite of the meticulous surgery we would hope for: remove 
a wedge, retighten, and hope for as much scar tissue as possible to produce tearing and bleeding with next 
coitus. Egad! Not the type of surgery I’d like—but maybe just what the patient wants!” (Goodman, et al., 
2007, p. 270). 
Andrew T. Goldstein and Gail R. Goldstein described four areas for ethical concern: autonomy 
(patient choice not influenced by outsiders or physicians); non-malfeasance (medical standard of care), 
beneficence (professional delivery of right patient outcome), and justice (equitable use of resources; cost 
of such elective procedures is carried by each patient and not borne by society through insurance plans) 
(Goodman, et al., 2007, pp. 272-273). Inadequate knowledge could compromise informed consent 
because FCGS is too new to anticipate the consequences (Braun, 2010).
What is in a woman’s best interests might not even be properly guided by current medical views on 
women’s sexual health. The New View Campaign (2010), mentioned above, argues that women and men 
have different sexual needs, women’s needs not being adequately recognized by prevalent medical 
standards. The New View Campaign would redirect attention to four main areas where sexual problems 
could be generated by the socio-cultural, political and economic context; partner relationships;
psychological factors and medical factors. (See New View Campaign, Manifesto, 2010). What the New 
View Campaign decries as the medicalization of sex could, in some respects, be called the disempowering
of physician ethics: the power of physicians to give or withhold medical intervention for the sake of
avoiding harm, compromised by the pressure for profits. Profit-making is already a motivating factor for 
physicians. 
     Sklar warns (Goodman, et al., 2007) of using patient satisfaction as a gauge rather than medical 
benefit. FCGS could conceivably make people feel better psychologically but the surgery could result in
untold harm later (pp. 274-275). Margins of risk acceptable in a utilitarian analysis might not be
acceptable to an ethical physician (Liao, et al., 2009, quoted in Braun, 2010, p. 1400). The development
of competitive and ethical alternatives through such a concerted effort may well be possible only through 
oversight, which is absent or ignored (e.g., ACOG) by the surgeons. 
Ethics and Oversight 
There is no federal or state legislation that prohibits or limits FCGS as yet in the United States. The 
FDA doesn’t regulate such procedures. However, there is no assurance that federal or state legislatures 
won’t regulate or even ban forms of FCGS in the future. Representatives from various feminist groups
may eventually voice their objections and be heard. Ethical controversies cast doubts on the legitimacy of 
the FCGS business. Plastic surgeons performing it don’t feel constrained but the ACOG advised against 
the practice, as mentioned above. LaSandra Cooper, Senior Media Relations Associate of the American 
Society of Plastic Surgeons (ASPS) stated (email, November 1, 2010): “The ASPS has not released a 
formal position or statement on these procedures. We largely concur with the ACOG statement and defer 
to our OB-Gyn colleagues as these procedures are primarily in the scope of practice of the gynecologist.” 
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     Fraudulent marketing could invite interventions from the Federal Trade Commission or pose dangers
by attracting patients who are not good candidates for the surgery, perhaps for psychological reasons,
bringing in public health agencies for oversight. Fraud, the intentional misrepresentation of material facts
coupled with justifiable reliance by the patient, could be hard to prove; after all, everyone understands
that promotional marketing celebrates the promise less than it discloses the risks and flaws. Television or 
radio ads extol the virtues of products and then quickly in nearly unintelligible voices or tiny print explain
the risks. Braun (2010, p. 1398) reports “one group of surgeons” proclaimed a woman that had an FCGS 
procedure done later married a professional golfer. One wonders whether the union would have been
reported had she married a caddy. Advertisements promising greater happiness are common; such claims 
are known as ‘puffing’ and they are legal. For FCGS, is the trust often placed in the medical profession
being exploited? Claims of improved sexual pleasure and psychological well-being appear in the 
advertising for these procedures (Braun, 2010, pp. 1398-1399), but FCGS could damage highly sensitive 
nerve fibers contained within the labia minora, which are linked to sexual arousal and compromise
sensitivity. Doctors warn of damaged labia (Triffin, 2010).
     An ethical view in favor of FCGS reasons that such choices, however questionable in terms of risk, are
essential to the constitutional right to privacy. A person has a right to express oneself with one’s body.
The right to privacy under the United States Constitution has been interpreted by the United States 
Supreme Court to be concerned with issues involving family planning and personal decisions about
intimate relationships (e.g., Griswold v. Connecticut, 1965; Lawrence v. Texas, 2003). Desires to 
reconstruct genitalia could easily be related to such privacy interests, particularly since sexual 
relationships, not just personal image, are implicated. 
     Entrepreneurial plastic surgeons would ideally frame or reframe their business in favorable ethical,
philosophical, or even religious principles or terms. However, it would seem difficult to frame support for 
FCGS in this context. The frame commonly used is the desire to have genitalia that would be attractive to
a porn star or stripper or at least not obviously visible in a bikini.
Could FCGS Undermine the Experience of True Beauty?
The emphasis on sexuality in modern culture drives aesthetics away from appreciation (and judgment) 
of beauty and toward anything that promises sensual excitement, eroticism becoming an easy standard for 
maximizing pleasure. The goal is not to be admired for beauty but to be admired as a sexual object. The 
aesthetics of FCGS are intertwined with its marketing (Triffin, 2010). That which is aesthetically pleasing 
is not necessarily beautiful; indeed, it may be just the opposite.
Defining beauty is, as Socrates noted, an arduous task, and even aesthetic theory, dealing with the arts, 
has no settled definition of the beautiful. However, philosophers and scholars have identified significant
features that beauty displays. Beauty can help humans identify whatever is appropriate and good (Plato, 
Hippias Major). Beauty, the object of love, is related to perception and appreciation of perfect ideal forms 
that can be glimpsed in the imperfect realities of human existence (Plato, The Symposium). These 
propositions do not suggest that a woman’s beauty should be measured by how much carnal desire she
provokes. 
Scarry (1999) argues that beauty draws humans outside of themselves, allowing the experience of 
loving that which is the other. To encounter beauty is to long for that which is beyond the self. Beauty 
offers a vision of harmony, order, and truth that stimulates longing to find beauty in many things, which 
necessarily develops what Scarry describes as lateral disregard, the capability that allows beauty and its 
illuminating experiences to be sought in other places even where one might least expect to find it.
Cope (2007), in “Beauty: An Essential Characteristic of Civilized Culture,” concludes that someone 
without an ability to judge beauty will not be exposed to values that transcend the political, economic, and 
cultural spheres and will lack discernment in the face of conflicting demands. A holistic view of beauty
enhances critical thinking. Elliot (2003) cautions that in America, excessive preoccupation with one’s
looks or personality can result in failing to meet demanding expectations of how one presents oneself.
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     Incorporating aesthetics through artificial means not just into material things but into the body itself
manipulates the way that beauty is experienced and understood and the way the body is experienced and 
understood as well. Is this a world where to function well is to exude sexuality? Braun writes:
Psychology provides a moral justification for cosmetic surgery, rendering it acceptable. Through
reference to psychology, even aesthetic procedures can be reframed as about functionality and as 
a legitimate way to move beyond bodily distress. For instance, breast augmentation surgery has
been identified as “a means of establishing congruency between the body and mind, or 
developing and embodied self that was comfortable” (2010, p. 1399).
Prospective patients, concerned that physicians might doubt their simple desire to look sensually erotic,
may try to stress physical discomfort, answers that will result in approval being medically-indicated 
(Braun, 2010, p, 1399).
     The Scottish philosopher Hume explained the human desire people feel to become whatever society
will admire or envy. Unlike Aristotle’s ideal person anxious to contribute to a society that appreciates 
justice, compassion, temperance, and a well-lived life, Hume’s ideal person imitates what society deems 
attractive. MacIntyre explains: 
Aristotle’s presupposed social context is one in which evaluation is primarily in terms of the 
achievement of the ends of activity; Hume is one in which evaluation is primarily in terms of the 
satisfaction of consumers. The individual envisaged by Aristotle engages in practical reasoning
not just qua individual, but qua citizen, of a polis; the individual as envisaged by Hume engages 
in practical reasoning qua member of a type of society in which rank, property, and pride 
structure social exchanges (1988, p. 298). 
     Gever’s observations about the philosophical aspects of cosmetic surgery focus on Kant and Hume and 
bear quoting at length:
Following Kant, one aspires to metaphysical, universal, categorical virtues and suffers from guilt 
when unable to measure up. The alternative morality, theorized by Hume, is more pragmatic, 
based on what he regarded as natural virtues exemplified by social norms. The kind of moral
opprobrium this system inculcates is shame, which comes about when one is excluded or 
ridiculed by others. Of course, shame understood as inadequate self-esteem also describes the 
feelings that motivate many to undergo cosmetic surgery (Gever, 2010, pp. 117-118).
What others ‘see in me’ in the blink of an eye may come to matter more than virtue. Cosmetic surgery 
responds directly to individuals competing to be the most beautiful (Healy, 2004). When physicians
portray images of what constitutes good-looking female genitalia (Braun, 2006), society is urged to
question all beauty in nature: perhaps nature is not really beautiful at all. Society might begin to expect a 
prescribed standard to resolve the question of beauty. Ease of reference to some authority displaces the 
individual analysis of beauty that could lead to moral growth.
     Personal preferences of physicians who are unaware of the range of normal labial size could result in 
unnecessary surgery and risk (Braun, 2010, p. 1402), and “ideally, assessment should not be conducted by 
those with fiscal interest in the outcome” (p. 1398). The aesthetic notions informing these practices run 
into the ground the natural diversity of female genitalia (Braun, 2006).
Pornography has been identified as one of the sources women use when they discuss their desire for 
designer vaginas with plastic surgeons. But pornography leads to a degrading objectification of humanity,
and the more pornography seizes from healthy sexuality, the more it portends disaster for loving
relationships. Women have a right to equal treatment for women but such equality of treatment is at risk 
when they are treated as fungible objects whose basic humanity can be ignored while their utility as 
sexual objects predominates as in pornography.
For Nusssbaum (1999), sex is not what causes objectification of sexual others resulting in their loss of
humanity. Rather the desire to objectify the sexual other is due to deformed attitude regarding things and
people.
Attending to the body and enjoying sexual functions is healthy behavior until happiness is viewed as 
consisting solely in sex and sexual attraction. Sexuality incorporates objectification, the desire for an
orgasm as a desire to fall away from the self into a state of unconscious ecstasy, what poets for centuries
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have often compared to a kind of loss of self, a death. Nussbaum, when describing how much sexuality 
rightly involves “intense focusing of attention on the bodily parts” (1999, p. 233), explains that this kind 
of mutually shared delight allows partners to become vulnerable and exposed without fear.
     Yet when one partner’s feelings are simply those of inadequacy, when the entire sexual act is burdened
by fears of how one’s genitalia appear, then healthy attention to bodily functions and parts during sex is 
converted into an unhealthy obsession. Attention to specific parts of the body allows those parts to insist a 
woman’s happiness be measured by how many stars are awarded to her for the up close screen shots of 
bedroom activity. Doctors advocating surgical procedures for genitalia communicate modes of evaluation:
…we’d argue that by offering these services, doctors are sending the message that there’s a right 
way for a vagina to look. While clicking through images of patients’ genitals on Power Point 
slides, the speakers made comments like “This is not so pleasant looking” and “Notice the 
aesthetic improvement.” One even defined cosmetic gynecology as “transforming female external 
genitalia to an aesthetically pleasing look”—implying it’s unpleasant to begin with. Appearance 
isn’t the only thing these M.D.s claim their procedures can improve; they also suggest they’ll
boost male attraction (Triffin, 2010).
Dangers of objectification of women become evident when one considers Nussbaum’s “seven ways to
treat a person as a thing”: 
1. Instrumentality. The objectifier treats the object as a tool of his or her purposes
2. Denial of autonomy. The objectifier treats as the object as lacking in autonomy and self-
determination 
3. Inertness. The objectifier treats the object as lacking in agency, and perhaps also in 
activity 
4. Fungibility. The objectifier treats the object as interchangeable (a) with other objects of 
the same type and/or (b) with objects of other types
5. Violability. The objectifier treats the object as lacking boundary integrity, as something
that it is permissible to break up, smash, break into
6. Ownership. The objectifier treats the object as something that is owned by another, can 
be bought or sold, etc. 
7. Denial of subjectivity. The objectifier treats the object as something whose experience 
and feelings (if an) need not be taken into account (Nussbaum, 1999, p. 218).
Some of these views of things are appropriate for ordinary objects, discarded when they lose their 
utility. Yet even inanimate things can merit protection beyond utility. Photographs of loved ones have 
sentimental value, even when they fade. Pornography presents women as things: tools for sexual 
excitement, whose own interest, feelings, or activity is meaningless except insofar as their activity 
contributes to the objectifier’s erotic experience. Women in this context are interchangeable. Women in 
this context are broken up into their sexual parts. They have no boundaries and are completely accessible, 
completely destructible at will (See Nussbaum, 1999, pp. 218-239). 
     The problem with pornography is that the real face, the real person, does not matter: large breasted 
women can easily be substituted for large-breasted women: women are as fungible as cars, washing 
machines, and fuzzy toys (Nussbaum, 1999, pp. 234-235). The woman has no life beyond her sexual
parts: “For what Playboy [sic] repeatedly says to its reader is, Whoever this woman is and whatever she 
has achieved, for you she is cunt, all her pretensions vanish before your sexual power. For some she is a 
tennis player—but you, in your mind can dominate her and turn her into cunt” (Nussbaum, 1999, pp. 235­
236).
Even an FCGS enterprise that went to great lengths to avoid pornographic representations would not
be able to overcome the influence of the cosmetic industry on women’s perceptions of their bodies. 
Women might not think they are searching for the porn star; rather, they want the exclusive five-star 
refurbishment. That could be read into desires for “a ‘neat’ vulva that resembles that of a prepubescent 
girl, a fleshy but smooth-skinned (and firm) vulva…a ‘nicely’ hooded and ‘contained’ clitoris” (Braun,
2010, p. 1401): innocent and smartly outfitted genitalia, nothing shameful here. 
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     Gever (2010) contends that modern preoccupations with visual media lead inevitably to a propensity to 
be entranced by mutable appearance as opposed to substance and enduring values.
How Does an Emphasis on Pornography Impact the Legitimacy of the Business?
Berer (2010) introduces the position of Ivo Pitanguy, the father of reconstructive and cosmetic surgery
in Brazil. His philosophy is that there is a right to beauty and harmony with one’s own image and 
surroundings. But a narcissistic preoccupation with the reflection in the mirror can easily result, not 
harmony (Braun, 2006).
     That pornographic magazines and hard-core DVDs might legitimately turn up on the physician’s
bookshelf alongside Grey’s Anatomy is a dismal idea. According to Sklar (Goodman, et al., 2007, p.
274), while professionals differ on the right labial size, the issue of what is normal and abnormal is not 
resolved by the American Medical Association’s distinction between cosmetic surgery (for improved self-
image) and reconstructive surgery (to fix abnormalities). Preference for small genitalia in women
contrasts with “size matters” for men. A new frontier for standardization of female genitalia adds yet 
another dimension to potential sources of stigmatization for women, already suffering from the onslaught
of Madison Avenue images of artificial beauty.
SWOT Analysis, Unresolved Business Issues and a Strategic Plan 
     To legitimize the FCGS business, plastic surgeons need to analyze opportunities and threats in the 
external environment and identity their own strengths and weaknesses. However, the only strength
appears to be the surgeons’ self reports of success. A profound weakness is the lack of peer reviewed
research on the techniques employed and their outcomes. An opportunity is the customer base that keeps 
the surgeons busy and profitable but a real threat exists in terms of regulation and lawsuits from unhappy 
customers. The unresolved business issues include the following:
1. The technology is not mature in that it has not yet been presented in peer reviewed 
publications and the professional organizations are disapproving.
2. It’s unclear what happens to women that undergo FCGS in the long run. Does sexual 
satisfaction improve? Is there residual pain? 
3. Although regulatory bodies have not yet intervened they may.
4. Women’s groups have not yet made their voices heard but they still may.

     A strategic plan to legitimate it as a business could involve the following steps:
 
1. The first step is to perfect the technologies, a pre-requisite to the legitimacy of the
business. 
2. Entrepreneurs need to respond to customer need. Is there a need beyond a small group of 
women that accept the porn star standard? 
3. They need to identify, develop, and disseminate ethical and legal theories to enhance the 
moral legitimacy of their business. Beyond privacy what ethical justification is there? 
4. They need to ally with other interest groups to lobby elected officials and legislatures to 
fend off damaging policies and regulations. Would politicians want to support it and risk the 
wrath of women’s groups? It would be difficult to step forward in support of such an unusual 
practice.
5. With reliable revenue from customers, moral support from ethical theories, and
protection from laws and governmental policies, the business would be legitimate. But this is 
unclear at this point though some women and their surgeons have created a niche market. 
Epilogue
The FCGS business is ongoing. Surgeons hold annual meetings. Eventually the number of procedures 
performed will be publicized. 
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CONCLUSION 
In sociological literature, there are three kinds of legitimacy that are considered relevant to the 
viability of a new line of business: cognitive, normative, and regulatory. Cognitive legitimacy is about 
whether stakeholders are aware of the needs supposedly to be filled by the proposed business; normative 
legitimacy is about whether the proposed business conforms to the ethical opinions upheld by the 
majority of the stakeholders; regulatory legitimacy is about whether regulatory agencies approve the
proposed business. More often than not, normative legitimacy decouples from regulatory legitimacy. In 
the other words, a new line of business that is involved with ethical controversies may be unregulated or 
even endorsed by regulatory agencies. Consequently, entrepreneurs in this new line of business should 
focus on perfecting their products or services and on educating stakeholders about the utility of the 
products or services. In this article, two cases about new medical services are discussed, and a 
legitimizing strategy is proposed. However, trait selection was shown to be illegitimate as yet and
although practiced, FCGS is not supported by the medical establishment and medical ethicists. Yet it is 
ongoing.
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